CORRELATION BETWEEN SERUM TISSUE POLYPEPTIDE SPECIFIC ANTIGEN Level AND PROSTATE VOLUME IN BPH

Volume prostat menjadi informasi yang penting karena dapat memperkirakan kematian pada Benign Prostatic Hyperplasia (BPH).Volume prostat diukur menggunakan TRUS (Transrectal Ultrasonography) sebagai baku emas namun TRUS mempunyai beberapakekurangan. Dibutuhkan suatu tolok ukur lain yang dapat memperkirakan volume prostat. Tissue Polypeptide Specific Antigen (TPS)yang terdeteksi di peredaran terdiri dari fragmen sitokeratin yang terdapat dalam jaringan dan menunjukkan status proliferasi. Selepitel di BPH yang mengandung sitokeratin 18 akan mengalami hiperplasia sehingga dapat terdeteksi dengan pemeriksaan TPS. Tujuanpenelitian ini adalah membuktikan adanya kenasaban antara kadar TPS serum dan volume prostat. Subjek penelitian terdiri dari 28pasien BPH yang datang berobat ke Poli Rawat Jalan Urologi RSUD Dr. Soetomo Surabaya. Volume prostat diukur menggunakan alatTRUS. Kadar TPS serum diukur menggunakan metode ELISA (TPS® ELISA IDL Biotech). Kadar TPS serum berkisar antara 82,45–1771,5U/L (195,35±349,79 U/L). Volume prostat beragam antara 20,7-87,4 cm (34,70±15,31 cm). Tidak terdapat kenasaban positif yangbermakna antara kadar TPS serum dan volume prostat (p=0,404; r=0,164).

Download Full-text

Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients

Journal of International Medical Research ◽

10.1177/0300060520986284 ◽

2021 ◽

Vol 49 (1) ◽

pp. 030006052098628

Author(s):

Chen Xu ◽

Gang Zhang ◽

Jin-jin Wang ◽

Chun-xian Zhou ◽

Min-jun Jiang

Keyword(s):

Benign Prostatic Hyperplasia ◽

Elderly Patients ◽

Prostate Volume ◽

Specific Antigen ◽

Urine Volume ◽

Prostatic Hyperplasia ◽

Antigen Level ◽

Residual Urine Volume ◽

Safety And Efficacy ◽

Total Prostate Specific Antigen

Objective To assess the safety and efficacy of prostatic arterial embolization (PAE) for elderly patients with lower urinary tract symptoms secondary to large benign prostatic hyperplasia. Methods Twenty-eight patients (>80 years of age) with prostate volume >80 mL were enrolled from October 2016 to October 2019. PAE was performed using microspheres and functional results were evaluated at 1, 3, 6, and 12 months postoperatively. The following data were recorded: International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urine flow rate (Qmax), post-void residual urine volume, prostate volume and total prostate-specific antigen level. Results Selective prostatic arterial catheterization and embolization were achieved in 27 of 28 patients. Follow-up data were available for those 27 patients until 12 months postoperatively. Significant improvements were found at all postoperative time points in terms of the mean IPSS, mean QoL score, mean Qmax, mean post-void residual urine volume, mean total prostate-specific antigen level, and mean prostate volume. The overall complication rate was 46.4%. Conclusions PAE is an efficacious and safe treatment for elderly patients with large prostate volume; it may offer an effective approach for patients who are not candidates for open or endoscopic surgical procedures because of comorbidities.

Download Full-text